Purpose: Histological grade is an important prognostic factor in patients with non-muscle–invasive bladder cancer (NMIBC). However, interobserver variability is high. Previous studies have suggested that quantification of histological features is useful to objectify grading. We evaluated whether quantification of the mean nuclear area of the 10 largest nuclei (MNA-10), degree of aneuploidy (DNA index or DI) and mitotic activity index (MAI) are of diagnostic value for NMIBC grade. Additionally, prognostic value of the 3 measures was assessed. Material and methods: A consensus grade was determined by 3 uropathologists in 310 NMIBC tissues according to the World Health Organization (WHO) 1973 and the WHO2004. Logistic regression with forward s...
Purpose: We tested whether the combination of 4 established cell cycle regulators (p53, pRB, p21 and...
Transitional cell carcinoma(T.C.C) of bladder display an upredictable biological behavior.Morphologi...
PURPOSE To examine survival rates and to calculate the risk of disease recurrence, progression, o...
Background: European treatment guidelines for pTa and pT1 urinary bladder urothelial carcinoma depen...
Context: Grading is the mainstay for treatment decisions for patients with non–muscle-invasive bladd...
Aims: To evaluate whether ki-67 labelling index (LI) has independent prognostic value for survival o...
Artículo originalAims: To evaluate whether ki-67 labelling index (LI) has independent prognostic val...
Two classifications for bladder cancer grade are widely used; the World Health Organization (WHO) 19...
Bladder cancer is a common type of cancer, especially among men in developed countries. Most cancers...
BACKGROUND: Histologic grade is the most important predictor of the clinical outcome of non-muscle i...
Contains fulltext : 47399schalken.pdf (publisher's version ) (Closed access)The In...
For the purpose of establishing a quantitative pathologic diagnosis of transitional cell carcinoma i...
Objective: There is no consensus for grading when more than one grade is present in bladder carcinom...
Purpose: To evaluate molecular and immunohistochemical markers to develop a molecular grading of uro...
In urothelial cell type non-muscle invasive urinary bladder carcinoma, TNM stage and WHO grade are w...
Purpose: We tested whether the combination of 4 established cell cycle regulators (p53, pRB, p21 and...
Transitional cell carcinoma(T.C.C) of bladder display an upredictable biological behavior.Morphologi...
PURPOSE To examine survival rates and to calculate the risk of disease recurrence, progression, o...
Background: European treatment guidelines for pTa and pT1 urinary bladder urothelial carcinoma depen...
Context: Grading is the mainstay for treatment decisions for patients with non–muscle-invasive bladd...
Aims: To evaluate whether ki-67 labelling index (LI) has independent prognostic value for survival o...
Artículo originalAims: To evaluate whether ki-67 labelling index (LI) has independent prognostic val...
Two classifications for bladder cancer grade are widely used; the World Health Organization (WHO) 19...
Bladder cancer is a common type of cancer, especially among men in developed countries. Most cancers...
BACKGROUND: Histologic grade is the most important predictor of the clinical outcome of non-muscle i...
Contains fulltext : 47399schalken.pdf (publisher's version ) (Closed access)The In...
For the purpose of establishing a quantitative pathologic diagnosis of transitional cell carcinoma i...
Objective: There is no consensus for grading when more than one grade is present in bladder carcinom...
Purpose: To evaluate molecular and immunohistochemical markers to develop a molecular grading of uro...
In urothelial cell type non-muscle invasive urinary bladder carcinoma, TNM stage and WHO grade are w...
Purpose: We tested whether the combination of 4 established cell cycle regulators (p53, pRB, p21 and...
Transitional cell carcinoma(T.C.C) of bladder display an upredictable biological behavior.Morphologi...
PURPOSE To examine survival rates and to calculate the risk of disease recurrence, progression, o...